Back to KROS
JACOBS LEVY EQUITY MANAGEMENT, INC → KROS
JACOBS LEVY EQUITY MANAGEMENT, INC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$5.3M
Q3 2026
Peak value
$15.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $15.6M |
| Q1 2026 | $7.8M |
| Q2 2026 | $6.5M |
| Q3 2026 | $5.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.3M | 461.1K | — | — |
| Q2 2026 | $6.5M | 605.4K | — | — |
| Q1 2026 | $7.8M | 706.1K | — | — |
| Q4 2025 | $15.6M | 768.4K | — | — |